Strategy wants to pay dividends on all four of its U.S. preferred stocks every single day, weekends included, starting with STRC on November 1. My first reaction was that this could change everything. Then I did the arithmetic. The amount of money doesn't change at all; the shape of it does. The par
A paper led by Kenji Furuya of Japan's RIKEN institute finds that the water boiling off our solar system's third interstellar visitor, 3I/ATLAS, carries a deuterium-to-hydrogen ratio tens of times higher than any comet native to our own solar system — a chemical fingerprint the authors say points to
An email landed today announcing Binance.US's new self-custody wallet — no seed phrase, keys split three ways, "no single point of failure." I already own the product that pitch describes; it's called a Bitkey, and Block shipped it two years ago. Here's what's actually the same, what's genuinely dif
A BMJ systematic review of 69 randomised trials and 153,902 adults found calcium alone, vitamin D alone, and the two combined all produced little to no meaningful reduction in fractures or falls. One combination did clear statistical significance — but missed the review's own bar for a clinically me
"Folate" and "folic acid" get used as if they're the same word, and they aren't quite the same molecule. Here's the actual biochemical difference, why folic acid ended up in bread in the first place, and what a genuinely active — and fast-moving — body of research says about folate and autism, inclu
ZeroHedge's tape caught it in real time — US diesel futures down more than 7%, European diesel futures up more than 7%, inside the same hour, on the same headline: a 90-day US diesel export ban the White House is reportedly close to putting forward. The administration's own Energy Secretary says it
A university-led team just wrapped a 90-day season at Turkey's Durupınar formation — soil cores, ground-penetrating radar, and carbon readings 40% higher inside than out, but no dated wood yet. What was actually reported, the site's contested 65-year back-and-forth, and why this project's own transl
On September 28, the European Space Agency's JUICE spacecraft swings within 8,640 kilometres of Earth over the Indian Ocean, borrowing 3.5 kilometres a second of speed from our planet for free. It's the third of four such thefts on a roundabout route to Jupiter's icy moons that won't actually arrive
On September 22, Alibaba's chip unit T-Head unveiled the Zhenwu V900 at the company's Apsara Conference in Hangzhou — 216GB of on-package memory, a 1,200GB/s interconnect, and clusters scaling to 500,000 units, which CEO Eddie Wu called "the most powerful AI chip in China today." The obvious story i
On September 18, House Select Committee on China chairman John Moolenaar wrote to Trump urging him to close the "cloud services loophole" in chip export controls. Less than a week before Xi Jinping's first state visit to the White House since 2015, the letter's real weight falls on a second ask: cur
Paramount Skydance's roughly $110 billion purchase of Warner Bros. Discovery cleared its last legal obstacle this week, and the list of what one company now controls is almost absurd to read in one sentence: CBS and CNN, HBO and MTV, SpongeBob and Bugs Bunny, Harry Potter and Transformers. The feder
A tweet promoting a podcast with oncologist Azra Raza asks whether medicine should chase cancer's first cell instead of its last. The technology closest to doing that, GRAIL's Galleri blood test, had its first-ever FDA advisory panel hearing today. What it actually finds, what a 142,942-person trial
A WEHI-led study of roughly 900 gut biopsies from 80 people, published in Science, finds that intestinal cells in inflammatory bowel disease patients can stay primed for an inflammatory kind of cell death even during symptom-free remission — and the stronger that signal, the higher the relapse risk
A biotech company is about to put the first GPX4-modulating "senolytic" into a human trial for male pattern hair loss, after ex vivo human follicle data that matched or beat finasteride. It's a genuinely new mechanism after nearly thirty years of the same two drugs — but the data so far is six days
AIR Security disclosed "Plugin4Shell" on September 17, 2026 — a zero-click flaw in Claude Code, OpenAI Codex, GitHub Copilot and Gemini CLI that let a hijacked git branch silently swap in different code than the one a plugin manifest had pinned by commit hash. OpenAI's own four-line patch note descr
Novo Nordisk says its experimental drug CagriSema beat Eli Lilly's tirzepatide on weight loss in a head-to-head diabetes trial. It did — against a 5mg dose, not tirzepatide's strongest one. A second trial released the same day, against the 15mg dose, went the other way.
On September 22, 2026, Anthropic shipped Claude Opus 5.5 — its first new model since CEO Dario Amodei published an essay ten days earlier arguing the whole industry should deliberately slow down. It's 40 percent cheaper than Opus 5, runs about 30 percent faster, performs close to the pricier Fable 5
A UK Biobank study of 11,071 adults found that people with bedroom light above roughly 3 lux at night — dimmer than almost any lamp, but bright enough for closed eyes to register — developed a thicker, stiffer-pumping heart and higher rates of heart failure, stroke and atrial fibrillation years late